Blood pressure drug recall: FDA investigates foreign plants that made drugs with cancer-causing impurities A federal judge is expected to hear arguments from both sides as soon as Dec. 5.

Losartan blood pressure medication recall expanded again over cancer concerns, FDA says By Madeline Farber Fox News Published September 24, 2019 9:36am EDT ...

Camber Pharmaceuticals Inc. on Thursday recalled 87 lots of losartan that contained small amounts of N-Nitroso N-Methyl 4-amino butyric acid, or NMBA, the company said in a recall notice. It was ...

Anyone with questions about the latest recall may call Torrent Pharmaceuticals at 1-800-912-9561 24 hours a day, seven days a week. This article tagged under: United States India ...

(CNN) --A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan. The recall is due to an "impurity" that is ...

Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets.

Torrent Pharmaceuticals expanded its recall of losartan potassium tablets Thursday from eight to 10 lots of its 100 mg tablets. It says the lots can contain amounts of N-Nitrosodiethylamine, ...

The recall was expanded on June 11, 2019 to include six additional lots of bulk losartan potassium tablets, particularly two lots of 50 mg and four lots of 100 mg.

For more information regarding this recall contact Sandoz, by calling 1-800-525-8747 or visit us.sandoz.com. Picked For You Atogepant Efficacious for Patients With Chronic Migraine ...

LOSARTAN POTASSIUM TAB, USP 50mg, 1000-count bottles, NDC number 13668-409-10, Lot 4O50C005, expiration date 11/2019. LOSARTAN POTASSIUM TAB, USP 25mg, 90-count bottles, NDC number 13668-113-90 ...